Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
5
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,472
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Optical Science and Technology, SPIE′s 48th Annual Meeting, Vol. 5211
Author(s):
C Martineau
,
G Lemercier
,
C Andraud
,
I WANG
,
M Bouriau
,
P. L. Baldeck
Publication date:
2003
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
DPG Spring Meeting 2015 - Posters
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
1,472
ACTG 5211: Phase II study of the safety and efficacy of vicriviroc (VCV) in HIV+ treatment-experienced subjects: 48-week results [abstract]
Authors:
RM Gulick
Phase II study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients: ACTG 5211
Authors:
RM Gulick
,
Z Su
,
C Flexner
Co-receptor tropism in patients screening for ACTG 5211, a phase 2 study of vicriviroc, a CCR5 inhibitor. [Abstract 655]
Authors:
T. Wilkin
,
Z Su
,
D Kuritzkes
See all similar
Cited by
1
From Light to Structure: Photo Initiators for Radical Two‐Photon Polymerization
Authors:
Thomas Wloka
,
Michael Gottschaldt
,
Ulrich Schubert
See all cited by